Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Ulz, P; Geigl, JB; Speicher, MR; Heitzer, E.
Latest technological developments in the analysis of circulating tumor DNA
MED GENET-BERLIN. 2016; 28(2): 234-244.
Web of Science FullText FullText_MUG

 

Autor/innen der Med Uni Graz:
Geigl Jochen Bernd
Heitzer Ellen
Speicher Michael
Ulz Peter
Gendermonitor:
Altmetrics:

Abstract:
The analysis of circulating tumor DNA (ctDNA) and circulating tumor cells, often known as liquid biopsy, is a rapidly developing field of medical research. Although it has taken decades since the discovery of cell-free DNA for it to be recognized as a suitable biomarker, the clinical benefit of ctDNA with regard to monitoring therapy response, the identification of resistance mechanisms, and novel emerging actionable targets, in addition to the detection of minimal residual disease, has recently been proven in numerous studies. Owing to the great variability of ctDNA in the circulation, together with the high degree of fragmentation, ctDNA is a challenging analyte. However, in recent years technological advances have contributed to a variety of routine applications of ctDNA analysis becoming a reality, given that a number of additional regulatory hurdles can be overcome.

Find related publications in this database (Keywords)
Liquid biopsies
CtDNA analysis
Biomarker
Surrogate marker
Clinical oncology
Circulating tumor cells
© Meduni Graz Impressum